The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
,_HQ_and_T7_RNA_polymerase,_HQ__From_left_to_right_256_384.jpg)
In 2030 over 50% of FDA approvals will involve AI discovered and developed drugs
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Subscribe To Our Newsletter & Stay Updated
